Related Experiment Video

Updated: Jul 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Blood transfusion-associated Pseudomonas fluorescens septicaemia: is this an increasing problem?

A E Murray, C A Bartzokas, A J Shepherd

    The Journal of Hospital Infection
    |May 1, 1987
    PubMed

    Insights

    Pseudomonas fluorescens transfusion-related septicaemia (TRS) is a rare but serious complication. This report details the first UK cases of TRS caused by this specific bacterium.

    Area of Science:

    • Medical Microbiology
    • Infectious Diseases
    • Hematology

    Background:

    • Transfusion-related septicaemia (TRS) poses a significant risk in healthcare.
    • Pseudomonas fluorescens is an opportunistic pathogen with potential for nosocomial infections.

    Observation:

    • Two distinct cases of severe septicaemia following blood product transfusion were identified.
    • The causative agent in both cases was confirmed as Pseudomonas fluorescens.

    Findings:

    • This represents the first documented instances of Pseudomonas fluorescens-induced TRS in the United Kingdom.
    • The clinical presentation and microbiological findings are detailed for both patients.

    Implications:

    • Highlights the need for enhanced vigilance and screening protocols for Pseudomonas in blood products.
    • Informs clinical practice regarding the diagnosis and management of rare bacterial sepsis post-transfusion.
    • Contributes to the understanding of Pseudomonas fluorescens as a pathogen in transfusion medicine.

    More Related Videos

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination10:32

    Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

    Published on: August 24, 2015

    Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa07:27

    Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

    Published on: July 12, 2018

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

    Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

    Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...